A PET study on the acute effect of ethanol on striatal D2 dopamine receptors with [C-11]raclopride in healthy males

被引:0
作者
Salonen, I
Hietala, J
Laihinen, A
Lehikoinen, P
Leino, L
Nagren, K
Ruotsalainen, U
Oikonen, V
Tuokkola, T
Nanto, V
机构
[1] UNIV TURKU, CENT HOSP, CENT LAB, FIN-20520 TURKU, FINLAND
[2] UNIV TURKU, DEPT PSYCHIAT, TURKU, FINLAND
[3] UNIV TURKU, CYCLOTRON PET CTR, FIN-20520 TURKU, FINLAND
[4] UNIV TURKU, DEPT CLIN CHEM, TURKU, FINLAND
关键词
ethanol; dopamine; PET; striatum; raclopride;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effect of acute oral ethanol intake (1.0 g/kg) on cerebral D2-receptors ([C-11]raclopride binding) was studied in seven healthy volunteers, using water and alcohol in two separate 59-min PET sessions. In the alcohol experiments, the blood ethanol concentration at the beginning of the imaging was 26.4+/-3.8 mmol/l and remained stable during the PET session. Ethanol was not found to influence binding of [C-11]raclopride to the dopamine D2 receptors in the human striatum, as indicated by the unchanged ratio B-max/K-d of the whole (left and right) striatum. The T-max values of the control and ethanol experiments did not differ in the whole striatum, but the right to left difference of striatal T-max was turned from negative to positive by ethanol (P=0.02). However, the difference between hemispheres in B-max/K-d was not significantly altered by ethanol intake. There was considerable interindividual variation in the response of all the above parameters to acute ethanol exposure. According to the present results, the acute effects of peroral ethanol exposure on striatal D2 receptor binding potential are of relatively small magnitude in man. However, the changes in T-max suggest that ethanol may influence the right-left difference of [C-11]raclopride binding. (C) 1997 by John Wiley & Sons, Ltd.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 50 条
  • [31] Effects of fluoxetine on dopamine D2 receptors in the human brain:: a positron emission tomography study with [11C]raclopride
    Penttilä, J
    Kajander, J
    Aalto, S
    Hirvonen, J
    Någren, K
    Ilonen, T
    Syvälahti, E
    Hietala, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (04) : 431 - 439
  • [32] Carbon-11 epidepride:: A suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors
    Langer, O
    Halldin, C
    Dollé, F
    Swahn, CG
    Olsson, H
    Karlsson, P
    Hall, H
    Sandell, J
    Lundkvist, C
    Vaufrey, F
    Loc'h, C
    Crouzel, C
    Mazière, B
    Farde, L
    NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (05) : 509 - 518
  • [33] Striatal Dopamine Release in Response to Morphine: A [11C]Raclopride Positron Emission Tomography Study in Healthy Men
    Spagnolo, Primavera A.
    Kimes, Alane
    Schwandt, Melanie L.
    Shokri-Kojori, Ehsan
    Thada, Shantalaxmi
    Phillips, Karran A.
    Diazgranados, Nancy
    Preston, Kenzie L.
    Herscovitch, Peter
    Tomasi, Dardo
    Ramchandani, Vijay A.
    Heilig, Markus
    BIOLOGICAL PSYCHIATRY, 2019, 86 (05) : 356 - 364
  • [34] Striatal dopamine D2 binding correlates with locus of control: Preliminary evidence from [11C]raclopride Positron Emission Tomography
    Vassena, Eliana
    Van Opstal, Filip
    Goethals, Ingeborg
    Verguts, Tom
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2019, 146 : 117 - 124
  • [35] Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography
    Alakurtti, Kati
    Aalto, Sargo
    Johansson, Jarkko J.
    Nagren, Kjell
    Tuokkola, Terhi
    Oikonen, Vesa
    Laine, Matti
    Rinne, Juha O.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2011, 31 (01) : 155 - 165
  • [36] Dopamine D2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [11C]-raclopride PET study
    Nakajima, Shinichiro
    Caravaggio, Fernando
    Mamo, David C.
    Mulsant, Benoit H.
    Chung, Jun Ku
    Plitman, Eric
    Iwata, Yusuke
    Gerretsen, Philip
    Uchida, Hiroyuki
    Suzuki, Takefumi
    Mar, Wanna
    Wilson, Alan A.
    Houle, Sylvain
    Graff-Guerrero, Ariel
    SCHIZOPHRENIA RESEARCH, 2015, 164 (1-3) : 263 - 267
  • [37] Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET
    Slifstein, M
    Hwang, DR
    Martinez, D
    Ekelund, J
    Huang, YY
    Hackett, E
    Abi-Dargham, A
    Laruelle, M
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (02) : 313 - 319
  • [38] Reduced striatal dopamine D2 receptors in people with Internet addiction
    Kim, Sang Hee
    Baik, Sang-Hyun
    Park, Chang Soo
    Kim, Su Jin
    Choi, Sung Won
    Kim, Sang Eun
    NEUROREPORT, 2011, 22 (08) : 407 - 411
  • [39] Differential regulation of striatal dopamine D1 and D2 receptors in acute and chronic parkinsonian monkeys
    Decamp, E
    Wade, T
    Schneider, JS
    BRAIN RESEARCH, 1999, 847 (01) : 134 - 138
  • [40] [11C]cyclopropyl-FLB 457:: A PET radioligand for low densities of dopamine D2 receptors
    Airaksinen, Anu J.
    Nag, Sangram
    Finnema, Sjoerd J.
    Mukherjee, Jogeshwar
    Chattopadhyay, Sankha
    Gulyas, Balazs
    Farde, Lars
    Halldin, Christer
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (13) : 6467 - 6473